| scholarly article | Q13442814 |
| P50 | author | Florian Kern | Q48662601 |
| Petra Reinke | Q62091040 | ||
| Hans-Dieter Volk | Q84015469 | ||
| P2093 | author name string | Axel Pruss | |
| Felix Kiecker | |||
| Rudolf Volkmer-Engert | |||
| Jan-Willem Gratama | |||
| Louis J Picker | |||
| Ralf Ewert | |||
| Elham Khatamzas | |||
| Ina-Maria Rudawski | |||
| Nicole Faulhaber | |||
| Torsten Bunde | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1709-1716 | |
| P577 | publication date | 2002-05-31 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals | |
| P478 | volume | 185 |
| Q40883276 | A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus. |
| Q36960608 | A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models |
| Q37696591 | A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology |
| Q34365057 | A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles |
| Q40193878 | A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus-specific human CD4 and CD8 T lymphocytes |
| Q36228210 | Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation |
| Q36223710 | Advances in understanding immunologic control of HIV infection |
| Q40468704 | An acidic cluster of human cytomegalovirus UL99 tegument protein is required for trafficking and function. |
| Q46678222 | Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals |
| Q33369455 | Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes |
| Q79844463 | Association between the HLA haplotype and the TCR-Vbeta repertoire of anti-hCMV specific memory T-cells in immunocompetent healthy adults |
| Q37213897 | Biologic and immunologic effects of knockout of human cytomegalovirus pp65 nuclear localization signal |
| Q36402863 | Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects |
| Q36012455 | CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals |
| Q38741001 | CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients |
| Q33280303 | CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects |
| Q40332290 | CMV-Specific T-cell Responses at Older Ages: Broad Responses With a Large Central Memory Component May Be Key to Long-term Survival |
| Q102056758 | COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+ |
| Q35946943 | Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins |
| Q44373650 | Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment |
| Q33825748 | Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns |
| Q92758330 | Circulating gluten-specific, but not CMV-specific, CD39+ regulatory T cells have an oligoclonal TCR repertoire |
| Q35826628 | Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial |
| Q55259946 | Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. |
| Q27487966 | Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness |
| Q47111092 | Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance |
| Q92700219 | Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients |
| Q47279129 | Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool |
| Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
| Q40515663 | Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. |
| Q49507866 | Current perspectives on the role of CD8+ T cells in systemic sclerosis |
| Q36199934 | Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation |
| Q37559627 | Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation |
| Q35922928 | Cytomegalovirus in hematopoietic stem cell transplant recipients |
| Q36994757 | Cytomegalovirus infection: a driving force in human T cell immunosenescence |
| Q37728492 | Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. |
| Q35086196 | Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. |
| Q33528999 | Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease |
| Q36499894 | Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size |
| Q39484819 | Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast |
| Q38859818 | Design of cocktail peptide vaccine against Cytomegalovirus infection |
| Q92650506 | Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen Presentation |
| Q36474240 | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 |
| Q34207966 | Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice |
| Q37095344 | Dynamics of T cell memory in human cytomegalovirus infection |
| Q92264958 | Early T Cell Differentiation with Well-Maintained Function across the Adult Life Course in Sub-Saharan Africa |
| Q35157039 | Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro |
| Q41369662 | Evaluation of antigen-specific T-cell responses with a miniaturized and automated method. |
| Q53660426 | Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation. |
| Q53557075 | Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. |
| Q34975513 | Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. |
| Q33283524 | Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression |
| Q40207796 | Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. |
| Q33198743 | Flow cytometric enumeration of antigen-specific T lymphocytes. |
| Q36086786 | Genetic analysis of cytomegalovirus in malignant gliomas |
| Q93186387 | HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease |
| Q38650846 | HIV-1 Infection Is Associated with Depletion and Functional Impairment of Mycobacterium tuberculosis-Specific CD4 T Cells in Individuals with Latent Tuberculosis Infection |
| Q28080452 | Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectives |
| Q39156328 | Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies |
| Q33628719 | High throughput T epitope mapping and vaccine development |
| Q37308147 | High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control |
| Q36059298 | High-resolution analysis of the human T-cell receptor repertoire |
| Q35597100 | Human CD8(+) T-cell differentiation in response to viruses |
| Q37807749 | Human cytomegalovirus immunity and immune evasion |
| Q36023008 | Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection |
| Q36121073 | Human immunosenescence: is it infectious? |
| Q34162822 | Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors |
| Q36447548 | IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control |
| Q30814677 | Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data |
| Q33260079 | Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations |
| Q52903640 | Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion. |
| Q37050965 | Immunobiology of human cytomegalovirus: from bench to bedside. |
| Q35958223 | Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia |
| Q33597783 | Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation |
| Q33689001 | Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity. |
| Q21092179 | Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus |
| Q37568171 | Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response |
| Q37331842 | Manipulation of dendritic cell functions by human cytomegalovirus |
| Q28263313 | Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells |
| Q43265267 | Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method |
| Q39960613 | Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83). |
| Q63880176 | Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations |
| Q49886940 | Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity |
| Q37888687 | Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation |
| Q44245356 | Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65. |
| Q31133720 | Optimized determination of T cell epitope responses |
| Q36982384 | Optimizing peptide matrices for identifying T-cell antigens |
| Q57166485 | PD-1 Expression on -Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis |
| Q36006819 | Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response |
| Q35665881 | Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses |
| Q33325811 | Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides |
| Q41718407 | Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery |
| Q34272089 | Prevention of maternal cytomegalovirus infection: current status and future prospects |
| Q40329387 | Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells |
| Q34434818 | Progress toward an elusive goal: current status of cytomegalovirus vaccines |
| Q36403419 | Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells |
| Q92758335 | Proteome-wide analysis of T-cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile |
| Q40534919 | Quantitation of MHC tetramer-positive cells from whole blood: evaluation of a single-platform, six-parameter flow cytometric method |
| Q42276223 | Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells. |
| Q36399914 | Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease |
| Q33755053 | Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. |
| Q35584266 | Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. |
| Q33217629 | Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines |
| Q24814428 | Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" |
| Q43490355 | Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast |
| Q37211056 | Standardization and optimization of multiparameter intracellular cytokine staining |
| Q24811983 | Standardization of cytokine flow cytometry assays |
| Q46727960 | Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells |
| Q36164091 | T cell-mediated immune responses in human newborns: ready to learn? |
| Q36479882 | T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence? |
| Q37183914 | Tegument proteins of human cytomegalovirus |
| Q38910078 | The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients. |
| Q38547042 | The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients |
| Q38049899 | The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB. |
| Q73720189 | The presence and longevity of peripherally expanded donor-derived TCRalphabeta+ mature T lymphocyte clones after allogeneic bone marrow transplantation for adult myeloid leukemias |
| Q36884194 | Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. |
| Q45872498 | Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy. |
| Q33209970 | Use of peptides and peptide libraries as T-cell stimulants in flow cytometric studies. |
| Q36517156 | VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection |
Search more.